Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.


The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2012 5
2013 8
2014 6
2015 3
2016 4
2017 4
2018 2
2019 16
2020 7
2021 13
2022 4
2023 0
Text availability
Article attribute
Article type
Publication date

Search Results

60 results
Results by year
Filters applied: . Clear all
Page 1
Understanding type 1 diabetes: etiology and models.
Acharjee S, Ghosh B, Al-Dhubiab BE, Nair AB. Acharjee S, et al. Can J Diabetes. 2013 Aug;37(4):269-276. doi: 10.1016/j.jcjd.2013.05.001. Epub 2013 Aug 2. Can J Diabetes. 2013. PMID: 24070892 Review.
In vitro techniques to evaluate buccal films.
Nair AB, Kumria R, Harsha S, Attimarad M, Al-Dhubiab BE, Alhaider IA. Nair AB, et al. J Control Release. 2013 Feb 28;166(1):10-21. doi: 10.1016/j.jconrel.2012.11.019. Epub 2012 Dec 5. J Control Release. 2013. PMID: 23219961 Review.
Crystallography, Molecular Modeling, and COX-2 Inhibition Studies on Indolizine Derivatives.
Venugopala KN, Chandrashekharappa S, Tratrat C, Deb PK, Nagdeve RD, Nayak SK, Morsy MA, Borah P, Mahomoodally FM, Mailavaram RP, Attimarad M, Aldhubiab BE, Sreeharsha N, Nair AB, Alwassil OI, Haroun M, Mohanlall V, Shinu P, Venugopala R, Kandeel M, Nandeshwarappa BP, Ibrahim YF. Venugopala KN, et al. Among authors: aldhubiab be. Molecules. 2021 Jun 10;26(12):3550. doi: 10.3390/molecules26123550. Molecules. 2021. PMID: 34200764 Free PMC article.
Anti-tubercular activity and molecular docking studies of indolizine derivatives targeting mycobacterial InhA enzyme.
Venugopala KN, Chandrashekharappa S, Deb PK, Tratrat C, Pillay M, Chopra D, Al-Shar'i NA, Hourani W, Dahabiyeh LA, Borah P, Nagdeve RD, Nayak SK, Padmashali B, Morsy MA, Aldhubiab BE, Attimarad M, Nair AB, Sreeharsha N, Haroun M, Shashikanth S, Mohanlall V, Mailavaram R. Venugopala KN, et al. Among authors: aldhubiab be. J Enzyme Inhib Med Chem. 2021 Dec;36(1):1472-1487. doi: 10.1080/14756366.2021.1919889. J Enzyme Inhib Med Chem. 2021. PMID: 34210233 Free PMC article.
Graphene-based hybrid nanoparticle of doxorubicin for cancer chemotherapy.
SreeHarsha N, Maheshwari R, Al-Dhubiab BE, Tekade M, Sharma MC, Venugopala KN, Tekade RK, Alzahrani AM. SreeHarsha N, et al. Int J Nanomedicine. 2019 Sep 12;14:7419-7429. doi: 10.2147/IJN.S211224. eCollection 2019. Int J Nanomedicine. 2019. PMID: 31686814 Free PMC article.
Computational Design, Synthesis, and Pharmacological Evaluation of Naproxen-Guaiacol Chimera for Gastro-Sparing Anti-Inflammatory Response by Selective COX2 Inhibition.
Shinu P, Sharma M, Gupta GL, Mujwar S, Kandeel M, Kumar M, Nair AB, Goyal M, Singh P, Attimarad M, Venugopala KN, Nagaraja S, Telsang M, Aldhubiab BE, Morsy MA. Shinu P, et al. Among authors: aldhubiab be. Molecules. 2022 Oct 14;27(20):6905. doi: 10.3390/molecules27206905. Molecules. 2022. PMID: 36296501 Free PMC article.
60 results